Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q3

9627.TEDINET S100QELB
Period2022-05-01 → 2023-01-31
Filed2023-03-17
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥263.9bn2022-05-01 → 2023-01-31Cons.Net sales
Revenue¥316.2bn2021-05-01 → 2022-04-30Cons.Net sales (5-year summary)
Revenue¥234.6bn2021-05-01 → 2022-01-31Cons.Net sales
Operating income¥11.7bn2022-05-01 → 2023-01-31Cons.Operating income
Operating income¥10.2bn2021-05-01 → 2022-01-31Cons.Operating income
Ordinary income¥12.4bn2022-05-01 → 2023-01-31Cons.Ordinary income
Ordinary income¥16.0bn2021-05-01 → 2022-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥10.8bn2021-05-01 → 2022-01-31Cons.Ordinary income
Profit before tax¥12.1bn2022-05-01 → 2023-01-31Cons.Income before income taxes
Profit before tax¥10.7bn2021-05-01 → 2022-01-31Cons.Income before income taxes
Net income (owners)¥6.6bn2022-05-01 → 2023-01-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥7.1bn2021-05-01 → 2022-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.2bn2021-05-01 → 2022-01-31Cons.Profit loss attributable to owners of parent
Net income¥6.6bn2022-05-01 → 2023-01-31Cons.Profit loss
Net income¥6.2bn2021-05-01 → 2022-01-31Cons.Profit loss
Total assets¥229.6bnat 2023-01-31Cons.Assets
Total assets¥212.5bnat 2022-04-30Cons.Assets
Total assets¥208.0bnat 2022-01-31Cons.Total assets (5-year summary)
Total liabilities¥105.8bnat 2023-01-31Cons.Liabilities
Total liabilities¥93.5bnat 2022-04-30Cons.Liabilities
Net assets / equity¥123.7bnat 2023-01-31Cons.Net assets
Net assets / equity¥119.0bnat 2022-04-30Cons.Net assets
Net assets / equity¥118.1bnat 2022-01-31Cons.Net assets (5-year summary)
Cash and deposits¥46.2bnat 2023-01-31Cons.Cash and deposits
Cash and deposits¥59.7bnat 2022-04-30Cons.Cash and deposits
EPS (basic)¥188.72022-05-01 → 2023-01-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥80.42022-11-01 → 2023-01-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥201.472021-05-01 → 2022-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥176.892021-05-01 → 2022-01-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.272021-11-01 → 2022-01-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.9%at 2023-01-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.0%at 2022-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio56.8%at 2022-01-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2022-05-01 → 2023-01-31¥8.7bn
Otherother segmentsrevenue external2022-05-01 → 2023-01-31¥8.7bn
Otherother segmentsrevenue intersegment2022-05-01 → 2023-01-31¥43m
Otherother segmentssegment ordinary income2022-05-01 → 2023-01-31−¥2m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2023-01-31−¥43m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2023-01-31−¥43m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2023-01-31−¥6.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2023-01-31¥236.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2023-01-31¥236.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2023-01-31¥18.0bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2023-01-31¥18.8bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2023-01-31¥18.8bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2023-01-31¥737m
—segment totalrevenue2022-05-01 → 2023-01-31¥263.9bn
—segment totalrevenue external2022-05-01 → 2023-01-31¥263.9bn
—segment totalrevenue intersegment2022-05-01 → 2023-01-31¥43m
—segment totalsegment ordinary income2022-05-01 → 2023-01-31¥18.8bn
Otherother segmentsrevenue2021-05-01 → 2022-01-31¥9.6bn
Otherother segmentsrevenue external2021-05-01 → 2022-01-31¥9.5bn
Otherother segmentsrevenue intersegment2021-05-01 → 2022-01-31¥71m
Otherother segmentssegment ordinary income2021-05-01 → 2022-01-31−¥108m
Reconciling Itemsreconcilingrevenue2021-05-01 → 2022-01-31−¥71m
Reconciling Itemsreconcilingrevenue intersegment2021-05-01 → 2022-01-31−¥71m
Reconciling Itemsreconcilingsegment ordinary income2021-05-01 → 2022-01-31−¥5.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue2021-05-01 → 2022-01-31¥209.8bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2021-05-01 → 2022-01-31¥209.8bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2021-05-01 → 2022-01-31¥17.8bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2021-05-01 → 2022-01-31¥15.3bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2021-05-01 → 2022-01-31¥15.3bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2021-05-01 → 2022-01-31−¥1.5bn
—segment totalrevenue2021-05-01 → 2022-01-31¥234.7bn
—segment totalrevenue external2021-05-01 → 2022-01-31¥234.6bn
—segment totalrevenue intersegment2021-05-01 → 2022-01-31¥71m
—segment totalsegment ordinary income2021-05-01 → 2022-01-31¥16.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Other eiPrior1YTDDuration16000000JPY
Other eiCurrentYTDDuration1000000JPY
Extraordinary incomePrior1YTDDuration366000000JPY
Extraordinary incomeCurrentYTDDuration113000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration194000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration153000000JPY
Impairment loss elPrior1YTDDuration61000000JPY
Impairment loss elCurrentYTDDuration183000000JPY
Loss on cancellation of leasehold contracts elPrior1YTDDuration119000000JPY
Loss on cancellation of leasehold contracts elCurrentYTDDuration－JPY
Other elPrior1YTDDuration54000000JPY
Other elCurrentYTDDuration36000000JPY
Extraordinary lossPrior1YTDDuration429000000JPY
Extraordinary lossCurrentYTDDuration372000000JPY
Income before income taxesPrior1YTDDuration10737000000JPY
Income before income taxesCurrentYTDDuration12108000000JPY
Income taxesPrior1YTDDuration4523000000JPY
Income taxesCurrentYTDDuration5497000000JPY
Profit lossPrior1YTDDuration6214000000JPY
Profit lossCurrentYTDDuration6611000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-16000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-17000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration6231000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration6628000000JPY
Profit lossPrior1YTDDuration6214000000JPY
Profit lossCurrentYTDDuration6611000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-15000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration14000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration30000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration18000000JPY
Other comprehensive incomePrior1YTDDuration15000000JPY
Other comprehensive incomeCurrentYTDDuration32000000JPY
Comprehensive incomePrior1YTDDuration6229000000JPY
Comprehensive incomeCurrentYTDDuration6643000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration6246000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration6661000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-16000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-17000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E04896-000DispensingPharmacyReportableSegmentsMember209793000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember15286000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember9530000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember234610000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration234610000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember71000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember71000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-71000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-04-30pass rounding
balance sheet identityconsolidated 2023-01-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-04-30pass
statement vs summary · net assetsconsolidated 2023-01-31pass
statement vs summary · net income attributable to parentconsolidated 2021-05-01/2022-01-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2023-01-31pass
statement vs summary · revenueconsolidated 2021-05-01/2022-01-31pass
statement vs summary · revenueconsolidated 2022-05-01/2023-01-31pass
statement vs summary · total assetsconsolidated 2022-04-30pass
statement vs summary · total assetsconsolidated 2023-01-31pass